Lorlatinib - Induced pulmonary arterial hypertension.
Chabrol A, Mayenga M, Hamid AM, Friard S, Salvator H, Doubre H, Fraboulet S, Metivier AC, Catherinot E, Rivaud E, Chaumais MC, Montani D, Couderc LJ, Tcherakian C.
Chabrol A, et al. Among authors: hamid am.
Lung Cancer. 2018 Jun;120:60-61. doi: 10.1016/j.lungcan.2018.03.023. Epub 2018 Mar 27.
Lung Cancer. 2018.
PMID: 29748016